Plasma asymmetric dimethylarginine in infants with bronchopulmonary dysplasia: a promising biomarker despite uncertain pathogenic significance
- PMID: 25454308
- DOI: 10.1016/j.jpeds.2014.10.039
Plasma asymmetric dimethylarginine in infants with bronchopulmonary dysplasia: a promising biomarker despite uncertain pathogenic significance
Comment on
-
Plasma asymmetric dimethylarginine levels are increased in neonates with bronchopulmonary dysplasia-associated pulmonary hypertension.J Pediatr. 2015 Feb;166(2):230-3. doi: 10.1016/j.jpeds.2014.09.004. Epub 2014 Oct 11. J Pediatr. 2015. PMID: 25311706 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical